http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2025, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 03 Dec 2025 08:30:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++TC+BioPharm+%28Holdings%29+++++++++++++++/25692763.html si-local-file:///var/storage/secattach/20251203/25692763.html http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++TC+BioPharm+%28Holdings%29+++++++++++++++/25692763.html Wed, 03 Dec 2025 08:30:00 -0500 O.52683874 T0U TCBPY http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++TC+BioPharm+%28Holdings%29+++++++++++++++/25692763.html si-local-file:///var/storage/secattach/20251203/25692763.html http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++TC+BioPharm+%28Holdings%29+++++++++++++++/25692763.html Wed, 03 Dec 2025 08:30:00 -0500 O.52683874 T0U TCBPY http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++TC+BioPharm+%28Holdings%29+++++++++++++++/25692763.html si-local-file:///var/storage/secattach/20251203/25692763.html http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++TC+BioPharm+%28Holdings%29+++++++++++++++/25692763.html Wed, 03 Dec 2025 08:30:00 -0500 O.52683874 T0U TCBPY http://www.streetinsider.com/Mergers+and+Acquisitions/CytoMed+completes+acquisition+of+T+cell+technology+for+China+market/25628473.html <p>CytoMed Therapeutics Limited (NASDAQ: GDTC) completed the acquisition of allogeneic gamma delta T cell technology from TC BioPharm Limited, a subsidiary of TC BioPharm (Holdings) PLC (OTC: TCBPY), according to a company statement.</p> <p>The acquired technology, designated TCB-002, previously completed a Phase I clinical trial in Europe and received orphan drug designation from the U.S. Food and Drug Administration for treating Acute Myeloid Leukemia.</p> <p>CytoMed plans to use the technology to develop cancer treatments for China and India markets. The Singapore-based company is in discussions with prospective partners to develop a manufacturing method for donor-derived gamma delta T cells using cytokines rather http://www.streetinsider.com/Mergers+and+Acquisitions/CytoMed+completes+acquisition+of+T+cell+technology+for+China+market/25628473.html Tue, 18 Nov 2025 08:00:54 -0500 GDTC TCBPY http://www.streetinsider.com/Mergers+and+Acquisitions/CytoMed+completes+acquisition+of+T+cell+technology+for+China+market/25628473.html <p>CytoMed Therapeutics Limited (NASDAQ: GDTC) completed the acquisition of allogeneic gamma delta T cell technology from TC BioPharm Limited, a subsidiary of TC BioPharm (Holdings) PLC (OTC: TCBPY), according to a company statement.</p> <p>The acquired technology, designated TCB-002, previously completed a Phase I clinical trial in Europe and received orphan drug designation from the U.S. Food and Drug Administration for treating Acute Myeloid Leukemia.</p> <p>CytoMed plans to use the technology to develop cancer treatments for China and India markets. The Singapore-based company is in discussions with prospective partners to develop a manufacturing method for donor-derived gamma delta T cells using cytokines rather http://www.streetinsider.com/Mergers+and+Acquisitions/CytoMed+completes+acquisition+of+T+cell+technology+for+China+market/25628473.html Tue, 18 Nov 2025 08:00:54 -0500 GDTC TCBPY http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+Nov+17/25622586.html si-local-file:///var/storage/secattach/20251117/25622586.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+Nov+17/25622586.html Mon, 17 Nov 2025 08:30:00 -0500 O.52683874 T0U TCBPY http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+Nov+17/25622586.html si-local-file:///var/storage/secattach/20251117/25622586.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+Nov+17/25622586.html Mon, 17 Nov 2025 08:30:00 -0500 O.52683874 T0U TCBPY http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+Nov+17/25622586.html si-local-file:///var/storage/secattach/20251117/25622586.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+Nov+17/25622586.html Mon, 17 Nov 2025 08:30:00 -0500 O.52683874 T0U TCBPY http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+Oct+07/25426816.html si-local-file:///var/storage/secattach/20251007/25426816.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+Oct+07/25426816.html Tue, 07 Oct 2025 07:00:00 -0500 O.52683874 T0U TCBPY http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+Oct+07/25426816.html si-local-file:///var/storage/secattach/20251007/25426816.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+Oct+07/25426816.html Tue, 07 Oct 2025 07:00:00 -0500 O.52683874 T0U TCBPY http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+Oct+07/25426816.html si-local-file:///var/storage/secattach/20251007/25426816.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+Oct+07/25426816.html Tue, 07 Oct 2025 07:00:00 -0500 O.52683874 T0U TCBPY http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+Sep+02/25284903.html si-local-file:///var/storage/secattach/20250902/25284903.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+Sep+02/25284903.html Tue, 02 Sep 2025 16:05:00 -0500 O.52683874 T0U TCBPY http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+Sep+02/25284903.html si-local-file:///var/storage/secattach/20250902/25284903.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+Sep+02/25284903.html Tue, 02 Sep 2025 16:05:00 -0500 O.52683874 T0U TCBPY http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+Sep+02/25284903.html si-local-file:///var/storage/secattach/20250902/25284903.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+Sep+02/25284903.html Tue, 02 Sep 2025 16:05:00 -0500 O.52683874 T0U TCBPY http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++TC+BioPharm+%28Holdings%29+++++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/25173553.html si-local-file:///var/storage/secattach/20250808/25173553.html http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++TC+BioPharm+%28Holdings%29+++++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/25173553.html Fri, 08 Aug 2025 13:02:00 -0500 O.52683874 T0U TCBPY http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++TC+BioPharm+%28Holdings%29+++++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/25173553.html si-local-file:///var/storage/secattach/20250808/25173553.html http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++TC+BioPharm+%28Holdings%29+++++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/25173553.html Fri, 08 Aug 2025 13:02:00 -0500 O.52683874 T0U TCBPY http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++TC+BioPharm+%28Holdings%29+++++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/25173553.html si-local-file:///var/storage/secattach/20250808/25173553.html http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++TC+BioPharm+%28Holdings%29+++++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/25173553.html Fri, 08 Aug 2025 13:02:00 -0500 O.52683874 T0U TCBPY http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+Aug+05/25150762.html si-local-file:///var/storage/secattach/20250805/25150762.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+Aug+05/25150762.html Tue, 05 Aug 2025 16:05:00 -0500 O.52683874 T0U TCBPY http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+Aug+05/25150762.html si-local-file:///var/storage/secattach/20250805/25150762.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+Aug+05/25150762.html Tue, 05 Aug 2025 16:05:00 -0500 O.52683874 T0U TCBPY http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+Aug+05/25150762.html si-local-file:///var/storage/secattach/20250805/25150762.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+Aug+05/25150762.html Tue, 05 Aug 2025 16:05:00 -0500 O.52683874 T0U TCBPY http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+May+27/24850641.html si-local-file:///var/storage/secattach/20250527/24850641.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+May+27/24850641.html Tue, 27 May 2025 08:30:00 -0500 O.52683874 T0U TCBPY http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+May+27/24850641.html si-local-file:///var/storage/secattach/20250527/24850641.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+May+27/24850641.html Tue, 27 May 2025 08:30:00 -0500 O.52683874 T0U TCBPY http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+May+27/24850641.html si-local-file:///var/storage/secattach/20250527/24850641.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++TC+BioPharm+%28Holdings%29++++For%3A+May+27/24850641.html Tue, 27 May 2025 08:30:00 -0500 O.52683874 T0U TCBPY http://www.streetinsider.com/Press+Releases/TCBP+Announces+Grant+of+European+Patent+for+Targeting+of+Microbial%2C+Oncological%2C+and+Viral+Indications+using+Modified+Gamma+Delta+T+Cells/24618678.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/gb.sco.edinbh" idsrc="xmltag.org" >EDINBURGH, Scotland</location></span>, <span class="legendSpanClass"><chron>April 9, 2025</chron></span> /PRNewswire/ -- <span value="OTC-PINK:TCBPY" idsrc="xmltag.org" >TC BioPharm (Holdings) PLC</span> ("<span value="OTC-PINK:TCBPY" idsrc="xmltag.org" >TC BioPharm</span>" or the "Company") (OTC: TCBPY) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced receipt of a patent, granted from the <span value="ACORN:0371859540" idsrc="xmltag.org" >European Patent Office</span> (EPO), for targeting microbial, oncological, and viral indications using modified gamma delta T cells.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/TCBP+Announces+Grant+of+European+Patent+for+Targeting+of+Microbial%2C+Oncological%2C+and+Viral+Indications+using+Modified+Gamma+Delta+T+Cells/24618678.html Wed, 09 Apr 2025 09:00:00 -0500 A.03718595 O.04906507 O.52683874 TCBPY http://www.streetinsider.com/Press+Releases/TCBP+Announces+Grant+of+European+Patent+for+Targeting+of+Microbial%2C+Oncological%2C+and+Viral+Indications+using+Modified+Gamma+Delta+T+Cells/24618678.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/gb.sco.edinbh" idsrc="xmltag.org" >EDINBURGH, Scotland</location></span>, <span class="legendSpanClass"><chron>April 9, 2025</chron></span> /PRNewswire/ -- <span value="OTC-PINK:TCBPY" idsrc="xmltag.org" >TC BioPharm (Holdings) PLC</span> ("<span value="OTC-PINK:TCBPY" idsrc="xmltag.org" >TC BioPharm</span>" or the "Company") (OTC: TCBPY) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced receipt of a patent, granted from the <span value="ACORN:0371859540" idsrc="xmltag.org" >European Patent Office</span> (EPO), for targeting microbial, oncological, and viral indications using modified gamma delta T cells.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/TCBP+Announces+Grant+of+European+Patent+for+Targeting+of+Microbial%2C+Oncological%2C+and+Viral+Indications+using+Modified+Gamma+Delta+T+Cells/24618678.html Wed, 09 Apr 2025 09:00:00 -0500 A.03718595 O.04906507 O.52683874 TCBPY